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Abstract
The aim of this chapter was to introduce the contents of neuropsychological assess‐
ment in multiple sclerosis, which should include the functional evaluation of cogni‐
tive  domains,  the  psychopathology  of  personality,  levels  of  depression,  and  the
assessment of psychosocial aspects and quality of life with multiple sclerosis. Further,
the most commonly used neuropsychological diagnostics are described. The chapter
hopes to draw attention to the importance of neuropsychological assessment which
should be a part of neurological diagnostics and therapy, including rehabilitation and
psychotherapy.
Keywords: neuropsychology, multiple sclerosis, cognitive deficit, neuropsychiatry,
neurorehabilitation
1. Introduction
Multiple sclerosis (lat. sclerosis multiplex) is a chronic disease of the central nervous system
caused by the damage of the myelin sheath. The symptoms of the disease depend on the location
of the damage in the nervous system and can vary: optic neuritis, paresthesia, motor symp‐
toms (spasticity), impairment of cranial nerves, oculomotor disorders, cerebellar disorders,
vertigo,  urinary disorders,  defecation,  sexual  dysfunctions,  fatigue,  depression,  cognitive
disorders, and paroxysmal symptoms. Multiple sclerosis is the most common cause of chron‐
ic neurological disabilities in young adults. The onset of the disease is usually between the ages
of 20 and 40. Its prevalence is higher among women. The highest susceptibility to the disease is
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among Caucasians; the geographic gradient of the incidence increases together with the distance
from the equator. Genetic predisposition plays a role.
1.1. Types of the disease
Four types of the disease are recognized according to their clinical course. In the early years
of the disease, the most common type is relapsing‐remitting MS (RRMS), occurring in 80–85%
of patients and characterized by attacks and remissions. If a previous attack left no neurological
deficit, remissions may be completely asymptomatic at the beginning of the disease. Half of
these patients develop into the stage of secondary progression (SPMS) during the first 10 years
of the disease's progression. This stage is characterized by a gradual increase in neurological
deficits that are already irreversible, with both the presence and absence of relapses that are
not as dramatic as in the remitting stage. The relapsing‐progressive (RPMS) form of the disease
is characterized by an increased neurological deficit also evident between the relapses; it is
thus prognostically the most unfavorable form of the disease. The primary progressive (PPMS)
form affects about 10–15% of patients and is characterized by a gradual increase in neurological
deficit. This form occurs more frequently among males and with a later onset of the disease [1].
In the relapsing‐remitting forms, approximately 20–30% of patients continue working
following their first attack. It is uncommon for patients in the early stages of this form of MS
to be physically disabled or to have noticeable alternations in terms of dementia. It is primarily
the progressive form of MS, developing at a later age that tends to pose more difficulty in the
cognitive domains, compared to the remitting one. Patients with the spinal form of the disease
have trouble mostly with motor skills and mobility. This form often occurs in the primary
progressive form. Cognitive deficits include impaired attention. The typical cognitive domains
impaired in the cerebral forms of MS are described below. Psychosocial and maladaptive
problems are described in the case report.
1.1.1. Case report 1
A woman of 47 years reported the first symptoms of MS (optic neuritis and paresthesia) at the
age of 17; later, the attacks recurred about once a year; the problems worsened after two child
deliveries. Therefore, she did not breastfeed her children, for which she blames herself for until
today. She underwent an abortion 2 years after the second birth due to the above‐mentioned
difficulties, then was psychiatrically treated, and still has feelings of guilt. The diagnosis of MS
was definitely confirmed about 4 years ago. The patient has since been considerably anxious,
unreconciled with the diagnosis, dominated by hostility and distrust of the medical staff (the
disease was not diagnosed correctly). MRI scans of the brain and spinal cord showed multiple
demyelinating lesions or plaques in the white matter. Nobody in the family had MS. She was
entitled to disability pension and has been taking antidepressants for 4 years, based on the
psychiatrist's indication of anxiety and depressive problems. Formerly, she worked as a
teacher. She feels very tired after only about a 3–4 km walk. She is married, has two adult sons,
and lives with her family. When she learned about MS, she was overtaken by fear of dying
and felt mentally ill, and thus stopped working. She did not observe any difficulties with
cognition. Gradually, a panic anxiety developed; when she wakes up, she feels scared, but this
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panic is also present while traveling; family members take her everywhere by car. The patient
is recommended to systematic cognitive-behavioral psychotherapy.
2. Cognitive functions and MS
The most characteristic feature of cognitive dysfunction in MS is the slowing down of proc‐
essing speed [2]. Another often affected domain is long‐term episodic memory and attention
(alternating and maintained). Less frequent but significant cognitive disorders include
disorders of executive functions (especially abstract and conceptual reasoning and problem‐
solving) [3].
2.1. Outline of basic neuropsychological techniques
Due to the high incidence of cognitive disorders in patients with MS, the adequate evaluation
and diagnosis of such deficits is of great importance. Their existence is often under diagnosed
during an ordinary neurological examination. Various tests are used to identify these.
One of the most significant neuropsychological studies of MS patients was carried out by Rao
[4]. The Brief Repeatable Battery (BRB) for neuropsychological impairment in MS [5] was
created based on a set of highly sensitive tests, with a few modifications. The BRB tests were
chosen with regard to time restrictions, and so the administration of the entire battery lasts
only about 40–45 min. It contains the following subtests: The Paced Auditory Serial Addition
Test (PASAT); The Symbol Digit Modalities Test (SDMT) measuring attention, visual accuracy,
and executive functions; The Selective Reminding Test (SRT) measuring verbal memory and
delayed recall periods; The Spatial Recall Test (SPART) measuring visuospatial memory and
delayed recall; and The Word List Generation (WLG) measuring verbal fluency. The battery
has 15 versions and is thus, despite its longer duration, the most commonly used battery for
the longitudinal monitoring of patients with MS. Clinical research supports the high sensitivity
of the battery. Its abbreviated version with 3 subtests has been under verification recently.
For cognitive screenings, Beatty [6] developed the Screening Examination for Cognitive
Impairment (SEFCI) neuropsychological battery, which proved to confirm cognitive deficits
typical of MS in a comparative study (duration 22 min) with other time‐consuming neuropsy‐
chological batteries. It does not have variants and is thus not suitable for longitudinal obser‐
vations. The study compared the battery with the Neuropsychological Screening Battery for
Multiple Sclerosis (NPSBMS) for which the administration period lasted 31 min. Both batteries
identified significantly more patients with cognitive impairment in MS than the Mini‐Mental
State Exam (MMSE) [7]. The Multiple Sclerosis Functional Composite (MSFC) is a score used
in clinical studies, measuring the function of the lower limb—timed walk, upper limb function
(nine‐hole peg test), and cognitive function (PASAT) [8, 9].
In 2001, the battery Minimal Assessment of Cognitive Function in MS (MACFIMS) [10] was
created with respect to neglected domains (higher cognitive functions and spatial processing),
and its reliability and validity has been verified in several studies. The MACFIMS battery
Cognitive Deficits and Neuropsychological Assessment in Multiple Sclerosis
http://dx.doi.org/10.5772/63968
213
includes the following tests: Controlled Oral Word Association Test (COWAT); Judgement of
Line Orientation Test (JLO); California Verbal Learning Test, Second edition (CVLT‐II); Brief
Visuospatial Memory Test‐Revised (BVMT‐R); Paced Auditory Serial Addition Test (PASAT);
Symbol Digit Modalities Test (SDMT); and the Sorting Test from the Delis‐Kaplan Executive
Function System (D‐KEFS). However, the MACFIMS battery is limited by time constraints and
for its need to be carried out by an experienced neuropsychologist. For this reason, a shorter
battery of cognitive tests has recently been designed. This consists of three subtests from the
MACFIMS battery and may be administered by neuropsychological workers without training
—International Brief Cognitive Assessment for Multiple Sclerosis—BICAMS [11]. It is suitable
for use in routine clinical practices in centers with no neuropsychologist to administrate the
MACFIMS. The BICAMS screening battery consists of three tests that are included in the
MACFIMS battery: SDMT, CVLT‐II (the first five experiments), BVMT‐R (the first three trials).
2.2. Cognitive domains and their examination
Cognitive deficits observed within MS can have almost any composition [12]; a typical profile
shows impairment of processing speed, memory, and often of executive skills as well [2].
2.2.1. Intellectual skills
Over the past two decades, numerous studies using neuropsychological assessment showed
that approximately half the patients exhibit some degree of cognitive impairment. We also
know that cognitive disorders may occur at any time during the illness and are not bound to
the presence of physical disorders [13]. Generally, a substantial variability of cognitive
impairments in MS in terms of their gravity and types has been described. Although approx‐
imately 10% of MS patients have severe problems that display extensive impairment even
when measuring overall intelligence, the vast majority (90%) of patients is affected only mildly
to moderately [14]. It should be emphasized that patients with MS as a group display a
relatively small decline on intelligence measures, and overall dementia is rare in MS [13].
Cognitive deficits in MS are usually more focal than generalized. Verbal IQ, therefore, often
remains intact during the first signs of MS [4].
2.2.2. Visuomotor skills, visuospatial skills, and attention
Visual disorders including diplopia, reduced color discrimination, blurred vision, and
transient blindness, and motor symptoms such as limb weakness, spasticity, incoordination,
or a combination of all the problems, as well as sensory disorders including numbness or
paresthesia, contribute to the alteration of visuomotor skills in neuropsychological examina‐
tions. Deficits of visual attention in MS patients significantly influence their level of visuomotor
skills. When evaluating visual attention, it is thus necessary to take into account the visual
disorders. For example, test results in automatic attention (reaction time) and focused attention
may be in norm in terms of errors, but the patient completes them in a longer period of time.
In contrast, controlled attention and divided attention are often deficient [15].
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2.2.3. Memory and learning
Long‐term memory is related to the learning and retrieval of new information. Patients with
MS often have difficulties with memory—the prevalence is reported between 40 and 65%. The
most common verbal memory tests are tasks in which the patient learns a wordlist [16].
Visuospatial memory, too, is affected in patients with MS [13]. Patients with MS have signifi‐
cant abnormalities of the hippocampal functional connectivity, even before spatial memory
impairment is apparent [17]. Patients with MS in the initial stages of the disease display a
relatively intact short‐term memory and learning ability, measured by tests of memory skills.
More patients experience problems in recalling new material, while recognition is rarely
altered.
2.2.4. Verbal ability and executive functions
Executive functions are related to planning and goal‐directed behavior. Drew and colleagues
[18] reported a series of executive dysfunctions—including disinhibition, poor fluency, and an
inability to shift sets. Overall, 17% of their sample of MS patients displayed this kind of deficit.
Language functions typically remain intact in MS; however, some minor deficits in under‐
standing were demonstrated. Weakened sentence comprehension has been associated with
slower information processing. Deficits in semantic memory and visual processing were also
observed [19].
Overall verbal skills in patients with MS are usually preserved for a long time, depending on
premorbid mental performance, flexibility, and vocabulary; a low level of verbal fluency is
observed. Dysarthria or problems with articulation are more prevalent in speech. The best and
longest preserved of all verbal skills is naming. Recalling information from long‐term memory,
vocabulary, and conceptual reasoning are often normal. If these abilities are altered, it is
usually the result of a generalized deterioration, or of the patient having low levels of pre‐
morbid education and of cognitive reserve. Some studies have found lower levels of conceptual
reasoning in patients with chronic progressive MS. A more detailed examination of verbal and
oral skills is possible with a complex speech assessment.
Cognitive impairment in MS, however, does not correlate with the degree of physical disability
(Expanded Disability Status Scale EDSS Kurtzke [20]); some studies showed a correlation with
disease duration, yet other studies did not prove this. The impairment of cognitive functions
correlates positively with some MRI abnormalities—mostly concerning atrophy, ventricular
dilatation, and the total volume of impaired white matter on W T2 lesion load. The sites of
predilection are areas of the corpus callosum, and extensive demyelination further affects
circuits linking the prefrontal and subcortical areas. Large confluent periventricular lesions
are also typical. As a whole, the huge variability in cognitive impairment may depend on many
factors, such as the patient's age, sex, age at disease onset, level of education, and cognitive
reserve [3]. Dysexecutive and prefrontal behavioral syndromes in a patient with a cerebral,
relapsing–remitting form are illustrated in the following case report.
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2.3. Case report 2
A woman of 54 years was treated for MS and migraine for 15 years. A cognition and personality
assessment was recommended by a neurologist for her memory problems. MRI of the brain
showed unique plaque lesions in the white matter, predominantly in the right frontal lobe; the
spinal cord was not affected. There has been improvement when comparing MRI scans, the
lesions were less apparent. The patient was entitled to a full disability pension 10 years ago.
She was a skilled saleswoman. She has been married for 35 years; her sons are adults. There
is no report of MS in the family. She commutes to a psychiatric clinic where antidepressants
are prescribed. She is oriented in contact, talkative, often gets lost, and exhibits signs of the
prefrontal syndrome. Memory problems have occurred for a longer period, approximately 10
or even more years. She misplaces thing and then cannot find them, someone talks about
something and she does not know about it, and she does not remember old information. She
also experiences sudden interruptions of activities when she goes off to do another one,
although she had not planned it; it is impulsive. She experiences confusions in her mind; she
wanted something and suddenly does not know what she was thinking about. It troubles her.
She “masks” these difficulties in front of her family and friends. Headaches occur daily.
Neuropsychologically, it is mainly attention that is impaired, and the generalized deterioration
of intellect is also striking, considering her education. It is possible to explain the problems
behaviorally, mainly through the prefrontal behavioral and dysexecutive syndromes, which
might be related to the largest findings of plaques in the frontal lobes. Cognitive behavioral
therapy and training of cognitive functions was advised.
3. The course of cognitive deficit
Studies on large MS patient samples have shown that the range of cognitive impairment
prevalence in MS is between 40 and 70% and appears in all stages and types of the disease
(which also includes the clinically isolated syndrome—CIS) [21]. It seems that observations
carried out for long enough are able to show cognitive impairment in progressive stages [22].
Several studies have confirmed the relationship between the dysexecutive syndrome and
frontal lesions, and others have focused on deficits in interhemispheric transfer (i.e., discon‐
nection syndrome) in the atrophy of the corpus callosum.
The course of a cognitive deficit without progression but with behavioral disorders is illus‐
trated in the following case report.
3.1. Case report 3
A 43‐year‐old man with the relapsing‐remitting form, treated for MS for 18 years, was initially
assessed due to problems with memory, concentration, exhaustion, and no sexual appetite.
An MRI scan of the brain showed small plaque lesions subcortically, compared with no
progression found on MRI scans 4 years ago. The patient had been treated with interferons for
3 years. He is left‐handed, a skilled auto‐mechanic, has his own workshop at home, and works
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17 h a day. He has been married for 22 years, has two children and “does not get on well” with
his wife, and he admits to extramarital relations. They are currently in a divorce proceeding.
The main problem is with his erection. Neuropsychologically, no striking impairment of
cognitive domains was found, and only anxiety and a conflictive family environment were
found. Marriage counseling, a sexologist, and conflict solving were recommended. The patient
refused the proposed recommendations and increasingly adopted strange and promiscuous
behaviors; he forced his wife and their children to move out of the house. He was incapable
of rational thinking; he explained the promiscuity as a verification of his sexual functions. A
1‐year follow‐up neuropsychological assessment showed no impairment of cognitive domains
and intellect, but a psychiatric examination was recommended due to paranoid thinking and
aggressiveness.
On the contrary, a rapid development of cognitive deficits into dementia can be seen in the
following case report.
3.2. Case report 4
A 42‐year‐old woman diagnosed with chronic progressive MS for 10 years was treated by
interferons for 6 years. At the time of her visit, eye problems are dominant for the first time;
she uses a white cane. She also experiences hearing difficulties, but does not complain about
memory at all. A former governess, now entitled to full disability pension, divorced, with two
children, both studying, not in contact with her ex‐husband. Her mother and brother help her
mostly, but the patient feels dependent and helpless. According to an MRI scan of the brain,
periventricular plaque lesions are apparent in the white matter of both hemispheres. There has
been a slight progression of plaque and atrophy when compared to an MRI from 4 years ago.
The initial psychological examination suggested a multi‐domain impairment, a decrease of
more than 2 SDs (verbal mnestic and visual skills, construction, executive functioning), with
severe anosognosia. The performance may have been influenced by her impaired visual and
auditory perception. Two years later, she comes fundamentally oriented, and the right eye is
blind. The outcome of the examination is a multi‐domain cognitive disorder; cognitive abilities
are significantly impaired across the whole profile.
4. Cognitive abilities and imaging methods
Magnetic resonance imaging (MRI) is used as one of the basic methods for diagnostics,
visualization, and monitoring of the inflammatory lesion dynamics in the brain and spinal
cord. The first MRI studies in patients with MS were published in 1981. It was found that
inflammatory lesions occur 5–10 times more than MS clinical attacks. Commonly used images
for the diagnosis of MS are those in which lesions of hyperintense signal of size from 1 mm to
several cm are apparent, located in the white matter of both hemispheres, mostly in the cerebral
ventricles, as well as in the brain stem, medulla, cerebellum, and upper cervical spinal cord. If
the radiologist wants to depict the active lesions, he/she applies gadolinium. The range of
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lesions visible in this way does not correlate with clinical disability as it is not known whether
the lesion is currently in the stage of reparation or destruction.
The only areas described as hypodensities (“black holes”) are areas where a loss of axons, thus
the definitive loss of tissue, has occurred. The typical brain damage in the white matter in MS
patients is clearly associated with a loss of axons [23]. Loss of axons is also a natural sign of
brain aging, and its verification is only possible postmortem.
Recent neuropsychological studies especially use functional magnetic resonance imaging
(fMRI) to assess the plasticity of functional cognitive deficits in patients with MS. The method
consists of recording the activation of brain areas during the presentation of various simple
neuropsychological tests. Compensatory mechanisms of cognitive functions already in the
early stages of chronic MS are described. The results of fMRI scans in a group of MS patients
with mild cognitive impairment and a healthy control group were compared. The functional
activation areas of the brain were completely distinct during the presentation of the verbal
naming test in each group (in MS patients in the frontal part of the right cortex and in the left
Brodmann's area, and in the right cingulate gyrus in the healthy group). The functional
reorganizations of motor functions are also described in fMRI assessments of MS patients,
when compared to healthy subjects. MS patients with mild cognitive deficits assessed by
neuropsychological tests were presented with auditory memory tests during an fMRI and were
found to display heightened activity in different areas. Patients with greater neuropsycholog‐
ical deficits were found to exhibit lower activation of brain areas during the fMRI assessment,
which probably supports the theory of adaptive mechanisms resulting from neural disorga‐
nization or inhibition associated with MS [24]. It is therefore also possible to explain the
unproven relationship between the extent of morphological findings of gliosis and plaques in
the white matter, and the severity and location of neuropsychological deficits in terms of this
plasticity of neuropsychological functions. The range of specific cognitive deficits, such as
memory disorders, reduced processing speed, and attention disorders, can be better explained
by the cortical gray matter lesions (lesions and atrophy) than subcortical white matter lesions
[25]. It has been shown that neocortical atrophy is associated with impaired verbal memory,
visual episodic and working memory, verbal fluency, attention/concentration, and processing
speed [26]. It is also possible that the neocortical atrophy is further responsible for slight
personality changes, such as euphoria, that are seen in MS patients [27]. The left frontal atrophy
occurs in patients with impaired verbal/auditory memory, while the right frontal atrophy is
associated with impaired visual episodic and working memories. The medial temporal cortex
atrophy is associated with a decrease in processing speed and impaired episodic and verbal
memories. The most important within the subcortical gray mater are atrophy, structural
changes, and an altered metabolism of the thalamus, which are associated with the impairment
of many cognitive domains [28]. Generally, it can be concluded that the cognitive impairment
observed in MS patients is caused by inflammatory lesions and a widespread loss of gray
matter. Although it is not possible to define the neuropsychological profile of MS patients as
strictly “cortical” or “subcortical”, it seems that it is the disruption of the cortical gray matter
which determines the degree and nature of cognitive dysfunction. Instead of the term sub‐
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cortical dementia, often associated with a severe multi‐domain cognitive impairment, the term
multiple disconnection syndrome is also used for cognitive deficits in MS [29].
5. Neuropsychiatric aspects of MS
Cognitive and affective disorders in MS have largely been ignored for many years, yet they
occur in 5% of the patients early in the disease, while in its advanced stages, this can be up to
70% of cases. MS is associated with a variety of behavioral changes. These may be associated
with emotional disorders and cognitive distortions and may often overlap. The prevalence of
depression is at least 50%; it is often manifested in parallel with the MS attack, and suicidal
tendencies may occur. The causes of depression are probably neuropathological changes
associated with the limbic system, neuroendocrinological, and psychoneuroimmunological
changes, responses to life change, or a side effect of MS therapy (especially corticosteroids).
The prevalence of bipolar disorders in MS is approximately 15%, and the prevalence of anxiety
disorders in MS is about 36%. The occurrence of bipolar disorder and psychosis in MS is twice
as common as in the general population, and the so‐called pseudobulbar affectation (invol‐
untary emotional expression disorder) affects one in ten patients. It is likely that the interrup‐
tion of frontolimbic and temporolimbic connections plays a role in the pathogenesis of
euphoria. Euphoric patients tend to have higher EDSS and a significantly more impaired
cognition, including anosognosia. The incidence of euphoria is lower (approximately 2%) than
is described in the older literature, thanks to an earlier diagnosis and treatment of MS.
Symptoms of depression do not correlate with neurological findings or with disease severity,
as measured by the sum of symptoms of physical disability and cognitive dysfunction [30].
However, depression positively correlates with subjective experience of stress, memory
deficits, and with age in elderly patients over 65 years of age, in patients with the chronic
progressive form and in patients with a predominance of spinal distortion. The neuropsycho‐
logical assessment should therefore, in addition to cognitive domains, also include assessments
of emotional alterations, especially depression and anxiety scales (e.g., methods HAD–
Hospital Anxiety and Depression Scale, BDI‐II) and their development over time [31].
Other changes in patients with MS, particularly changes in values and attitudes, progress
together with the psychosocial adjustment and are mostly associated with the subjective
perception of a physical handicap, but do not correlate with the duration of MS or other
demographic indicators. Specific quality of life with MS questionnaires is used to measure the
quality of life in these patients, such as the MSQOL‐54 [32], which measures 12 subscales:
physical function, role limitations—physical, role limitations—emotional, pain, emotional
well‐being, energy, health perceptions, social function, cognitive function, health distress,
overall quality of life, and sexual function.
The Multi‐domain battery Multiple Sclerosis Quality of Life Inventory (MSQLI) contains 10
scales, both generic and specific to MS [33]; some scales also have a shortened version: Health
Status Questionnaire (SF‐36), Modified Fatigue Impact Scale (MFIS), MOS Pain Effects Scale
(PES), Sexual Satisfaction Scale (SSS), Bladder Control Scale (BLCS), Bowel Control Scale
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(BWCS), Impact of Visual Impairment Scale (IVIS), Perceived Deficits Questionnaire (PDQ),
Mental Health Inventory (MHI), and MOS Modified Social Support Survey (MSSS). The scales
can also be presented individually.
6. Multi‐disciplinary MS treatment
6.1. Cognitive disorders therapy in MS
Pharmacotherapy for cognitive impairment in MS is currently the subject of intense research.
First and foremost, a preventive effect of early initiation and immunomodulatory therapy, in
association with the possible development of cognitive disorders, is assumed. The primary
point is to prevent axonal loss and the development of atrophy. Very few randomized trials
have been carried out so far. Acetylcholinesterase inhibitors have currently been examined,
through only with questionable or entirely negative results. No effective pharmacological
treatment for cognitive disorders in MS has yet been found [34]. The pharmacological manip‐
ulation of depression is also significant, however, and should always be combined with
psychotherapy in MS patients. Moreover, depression can be enhanced by a variety of bio‐
psychosocial factors, such as reduced work performance or increased neurological symptoms.
6.2. Neuropsychological rehabilitation and the cognitive deficit psychotherapy
Kalb and Reitman [35] report the so‐called cognitive rehabilitation as the basic therapy for
cognitive deficits. They present two approaches: The first is to restore functions, such as
through direct training and exercising of skills that are altered in neuropsychological tests (this
approach, however, has a limited benefit in improving daily activities in MS patients) and the
second approach is more compensatory, and closer to current neuropsychology, with its desire
to improve a function through substitution, that is, the individual use of residual cognitive
abilities in order to improve the quality of life through behavioral and cognitive therapy. The
first approach is based on a more experimental approach, while the second is more clinical. It
concerns creating an individual plan, “customized” for each patient.
This plan is based on neuropsychological assessment and interviews with the patient and their
family. The evidence for the efficacy of cognitive rehabilitation in MS is, unfortunately, quite
limited and contradictory. Memory rehabilitation studies suggest that individualized com‐
puter programs focused on patient‐specific difficulties could be most effective. The most
beneficial in the rehabilitation of executive functions is perhaps a direct instruction by a
therapist, that is, paper and pencil method. The main problem of cognitive training in MS
remains to be particularly its unavailability for patients and their often low motivation. It is
therefore very important to maintain employability of patients for as long as possible and
motivate them toward mental activity.
For these purposes, teams of multi‐disciplinary experts work with people with MS, where a
neurologist, psychologist, psychiatrist, speech therapist, occupational therapist, physiothera‐
pist, and a psychotherapist cooperate in complex, holistic, all‐day programs, based on
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cognitive as well as emotional, behavioral, and physiological changes. Even though it is
impossible to increase one's premorbid IQ and brain volume, we can work on cognitively
stimulating leisure activities. It is also very important to motivate the patient to lead an active
life that includes adherence to the prescribed pharmacotherapy, but also an active attitude
toward physiotherapy, psychotherapy, and cognitive training. It is the combination of
physiotherapy and cognitive training that has the correct effect on the neurogenesis and
formation of new synapses.
The specific model of psychosocial support for patients with MS at different levels, which has
the characteristics of a cognitive‐behavioral supportive therapy and family therapy, includes
[35]: (1) psychoeducation, that is, education leading to the understanding of the disease,
explanation of adaptive coping strategies; (2) diagnostics/treatment of emotional or cognitive
problems; (3) family intervention, that is, how to organize family support for members with
MS for adaptive coping with the illness; (4) work support for MS patients, that is, to work
productively in a field for as long as they are able and interested, and vice versa, to stop
working if necessary; (5) individual psychosocial assistance to individuals with MS. In addition
to professional psychotherapy, a support group of people with the same disease, but also of
family, friends, possibly a cultural‐social or religious community, is appropriate.
6.3. Disability, employability, and MS
The organization of care for MS patients is similar around the world. A patient with a benign
course of the disease is usually checked by a neurologist twice a year; more complicated
patients are consulted in centers for MS that are a part of most university neurological clinics.
In the case of a more severe disability, it is advisable to contact social services or long‐term
care. Neuropsychological approaches, however, show that employability can also be predicted
by a short battery of tests that focuses on relevant domains, such as the aforementioned battery
BICAMS [36]. The issue of employment restrictions, disability, work, and life disability due to
MS is illustrated in the following case report.
6.3.1. Case report 5
A doctor, surgeon specialist, formerly a chief physician, 50 years old, with remitting MS. MRI
scans revealed the cerebrospinal form with multiple plaques in the white matter of the brain
and spinal cord; the demyelinating plaque findings are unchanged for 3 years. The patient was
recommended to a cognition assessment for his memory problems, was dismissed from the
surgical specialty, and thus works as a GP, which does not satisfy him. He is divorced and has
problems with his second wife, who is a nurse, approximately 25 years younger. The wife is
hostile, blames him for the change of social status. Neuropsychologically, only his psychomo‐
tor speed and motor dexterity are slightly reduced, which exhibits moderate depression in
emotional experience, not suicidal. Couples therapy was recommended to address the changes
in his professional situation and partner quality of life, together with a psychiatric consultation.




This article summarizes a neuropsychologist's perspective on cognitive skills in MS. When
evaluating the cognitive level of patients, the comprehensive or screening assessment should
examine specific domains that may not correlate with the length of the illness, neurological
objective findings, the amount of plaque on MRI scans, and the MS form or type. Cognitive
disorders are a significant predictor of quality of life during all stages of MS; they reduce
physical independence and the ability to perform both activities of daily life and of employ‐
ment, they influence one's coping and compliance to the treatment and their rehabilitation
potential. The employability of people with MS can thus be easily predicted by the severity of
cognitive disorders and their premorbid cognitive reserves, rather than by physical disability.
The neuropsychological assessment of cognitive functions in MS should be a part of care for
patients with MS and a part of a multi‐disciplinary approach to neurorehabilitation.
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